{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:24:32Z","timestamp":1777587872601,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41434-018-0028-5","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T12:03:11Z","timestamp":1531742591000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose\u2013response and comparison to AAV PHP.B"],"prefix":"10.1038","volume":"25","author":[{"given":"Robert D.","family":"Dayton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mychal S.","family":"Grames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"28_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59\u201365.","journal-title":"Nat Biotechnol"},{"key":"28_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/mt.2009.71","volume":"17","author":"S Duque","year":"2009","unstructured":"Duque S, Joussemet B, Riviere C, Marais T, Dubreil L, Douar A, et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther. 2009;17:1187\u201396.","journal-title":"Mol Ther"},{"key":"28_CR3","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/mt.2010.191","volume":"18","author":"DB Wang","year":"2010","unstructured":"Wang DB, Dayton RD, Henning PP, Cain CD, Zhao LR, Schrott LM, et al. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther. 2010;18:2064\u201374.","journal-title":"Mol Ther"},{"key":"28_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu W, et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci. 2017;20:1172\u20139.","journal-title":"Nat Neurosci"},{"key":"28_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"BE Deverman","year":"2016","unstructured":"Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol. 2016;34:204\u20139.","journal-title":"Nat Biotechnol"},{"key":"28_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates. Mol Ther. 2015;23:477\u201387.","journal-title":"Mol Ther"},{"key":"28_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mtm.2015.36","volume":"2","author":"KL Jackson","year":"2015","unstructured":"Jackson KL, Dayton RD, Klein RL. AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult rats. Mol Ther Methods Clin Dev. 2015;2:1\u20138.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"28_CR8","first-page":"1","volume":"9","author":"KL Jackson","year":"2016","unstructured":"Jackson KL, Dayton RD, Deverman BE, Klein RL. Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B. Front Mol Neurosci. 2016;9:1\u201311.","journal-title":"Front Mol Neurosci"},{"key":"28_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","volume":"26","author":"J Hordeaux","year":"2018","unstructured":"Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice. Mol Ther. 2018;26:664\u20138.","journal-title":"Mol Ther"},{"key":"28_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/exnr.2002.7942","volume":"176","author":"RL Klein","year":"2002","unstructured":"Klein RL, Hamby ME, Gong Y, Hirko AC, Wang S, Hughes JA, et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurobiol. 2002;176:66\u201374.","journal-title":"Exp Neurobiol"},{"key":"28_CR11","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"G Gao","year":"2002","unstructured":"Gao G, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA. 2002;99:11854\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"28_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.mt.6300331","volume":"16","author":"RL Klein","year":"2008","unstructured":"Klein RL, Dayton RD, Tatom JB, Henderson KM, Henning PP. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther. 2008;16:89\u201396.","journal-title":"Mol Ther"},{"key":"28_CR13","doi-asserted-by":"crossref","unstructured":"Grames MS, Jackson KL, Dayton RD, Stanford JA, Klein RL. Methods and tips for intravenous administration of adeno-associated virus to rats and evaluation of central nervous system transduction. J Vis Exp. 2017;126:1\u20137.","DOI":"10.3791\/55994"},{"key":"28_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymthe.2005.10.008","volume":"13","author":"RL Klein","year":"2006","unstructured":"Klein RL, Dayton RD, Leidenheimer NJ, Jansen K, Golde TE, Zweig RM. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther. 2006;13:517\u201327.","journal-title":"Mol Ther"},{"key":"28_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mt.2013.88","volume":"21","author":"RD Dayton","year":"2013","unstructured":"Dayton RD, Gitcho MA, Orchard EA, Wilson JD, Wang DB, Cain CD, et al. Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther. 2013;21:1324\u201334.","journal-title":"Mol Ther"},{"key":"28_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","volume":"13","author":"CN Cearley","year":"2006","unstructured":"Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther. 2006;13:528\u201337.","journal-title":"Mol Ther"},{"key":"28_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1517\/14712598.2012.681463","volume":"12","author":"RD Dayton","year":"2012","unstructured":"Dayton RD, Wang DB, Klein RL. The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin Biol Ther. 2012;12:757\u201366.","journal-title":"Expert Opin Biol Ther"},{"key":"28_CR18","doi-asserted-by":"publisher","first-page":"e65646","DOI":"10.1371\/journal.pone.0065646","volume":"8","author":"G Jonquieres von","year":"2013","unstructured":"von Jonquieres G, Mersmann N, Klugmann CB, Harasta AE, Lutz B, Teahan O, et al. Glial promoter selectivity following AAV-delivery to the immature brain. PLoS ONE. 2013;8:e65646.","journal-title":"PLoS ONE"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2016.00013","volume":"9","author":"G Jonquieres von","year":"2016","unstructured":"von Jonquieres G, Fr\u00f6hlich D, Klugmann CB, Wen X, Harasta AE, Ramkumar R, et al. Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes. Front Mol Neurosci. 2016;9:1\u201314.","journal-title":"Front Mol Neurosci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0028-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:28Z","timestamp":1684617208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-018-0028-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1038\/s41434-018-0028-5","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"15 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}